Patents by Inventor Jared Robert

Jared Robert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250122580
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Application
    Filed: October 30, 2024
    Publication date: April 17, 2025
    Applicant: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12270082
    Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: April 8, 2025
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Publication number: 20250066862
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Application
    Filed: September 5, 2024
    Publication date: February 27, 2025
    Applicant: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12232456
    Abstract: Methods and systems for hydration of plants are provided. An example method includes generating structurally altered gas molecules from water. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into water. The method further includes providing the water infused by the structurally altered gas molecules to a plant. The structurally altered gas molecules cause improvement of at least one characteristic concerning growing of the plant.
    Type: Grant
    Filed: October 4, 2023
    Date of Patent: February 25, 2025
    Assignee: H2Plus LLC
    Inventors: Gene Dedick, Jared Roberts
  • Patent number: 12215392
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Grant
    Filed: April 11, 2024
    Date of Patent: February 4, 2025
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12215391
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: February 4, 2025
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Publication number: 20250034647
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 30, 2025
    Applicant: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12129345
    Abstract: Methods and systems for degradation of polymeric substances is provided. An example method includes generating structurally altered gas molecules from water, where the structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a matter containing the polymeric substances, where upon being infused, the structurally altered gas molecules cause a decrease in concentration of the polymeric substances in the matter.
    Type: Grant
    Filed: October 4, 2023
    Date of Patent: October 29, 2024
    Assignees: H2 Plus LLC, H2Plus Operations, LLC
    Inventors: Gene Dedick, Jared Roberts
  • Publication number: 20240355461
    Abstract: A healthcare management system is described. The system may include one or more nodes associated with a blockchain. The one or more nodes may include a blockchain ledger having patient information. The nodes may further include a processor configured to obtain a request from a patient to avail a medical procedure from a medical provider. The processor may obtain the patient information from the blockchain ledger responsive to obtaining the request. The processor may determine that a health saving account associated with the patient is linked with healthcare management system, and schedule an appointment for the medical procedure with the medical provider when the health saving account is linked with the system. In addition, the processor may determine a medical procedure authenticity, and deduct an amount associated with the medical procedure from the health saving account responsive to a determination that the medical procedure is authentic.
    Type: Application
    Filed: April 24, 2023
    Publication date: October 24, 2024
    Applicant: Smile Bridge, LLC
    Inventor: Jared Robert Burr
  • Publication number: 20240352511
    Abstract: A method of identifying and quantifying copy number variations in a gene of interest for a genomic DNA sample includes (i) fragmenting a genomic DNA sample to produce a plurality of polynucleotide fragments, (ii) isolating a plurality of target polynucleotide fragments, (iii) sequencing the plurality of target polynucleotide fragments, (iv) aligning fragment sequences to a reference sequence, (v) calculating read depths for base positions of the plurality of target polynucleotide fragments, (vi) calculating copy number likelihoods for each base position of the reference sequence, (vii) performing a breakpoint analysis on a set of fragment sequences to identify at least one sequence variation located between selected breakpoint regions of the target gene and calculate modified copy number likelihoods for base positions of the reference sequence based on the at least one sequence variation, and (viii) determining whether the target gene includes at least one copy number variation.
    Type: Application
    Filed: April 17, 2024
    Publication date: October 24, 2024
    Applicant: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Jared Robert Maguire, Alexander D. Robertson, Eric Andrew Evans
  • Patent number: 12122969
    Abstract: Methods and systems for fuel treatment are provided. An example method includes generating structurally altered gas molecules from water. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a fuel to modify properties of the fuel, thereby increasing fuel burning efficiency.
    Type: Grant
    Filed: October 4, 2023
    Date of Patent: October 22, 2024
    Assignee: H2Plus LLC
    Inventors: Gene Dedick, Jared Roberts
  • Patent number: 12104212
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Grant
    Filed: November 8, 2023
    Date of Patent: October 1, 2024
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Publication number: 20240294990
    Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.
    Type: Application
    Filed: May 15, 2024
    Publication date: September 5, 2024
    Applicant: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Publication number: 20240271224
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Application
    Filed: April 11, 2024
    Publication date: August 15, 2024
    Applicant: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12024749
    Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: July 2, 2024
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
  • Patent number: 12018391
    Abstract: Methods and systems for generation and deployment of a structurally altered gas molecules derived from water are provided. An example system includes a first container for combining purified water with a compound mixture being non-reactive with the water and a conductor of an electric field and a magnetic field. The system includes a magnetic field generator and an electric field generator designed to apply the magnetic field and the electric field to the combination of the purified water and the compound mixture to cause generation of the structurally altered gas molecules having a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the purified water. The system further includes a second container for introducing the structurally altered gas molecules into an environment of a chemical process to facilitate electron transfers during the chemical process, thereby increasing output of the chemical process.
    Type: Grant
    Filed: November 23, 2023
    Date of Patent: June 25, 2024
    Assignees: H2Plus LLC Operations, LLC, H2Plus Operations, LLC
    Inventors: Gene Dedick, Gustav Eriksson, Jared Roberts, David Hauschild
  • Patent number: 12000053
    Abstract: Methods and systems for generation and deployment of a structurally altered gas molecules derived from water are provided. An example method includes combining purified water with a compound mixture. The compound mixture is non-reactive with the water and a conductor of an electric field and a magnetic field. The method includes applying the magnetic field and the electric field to the combination of the purified water and the compound mixture to cause generation of the structurally altered gas molecules. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the purified water. The method further includes introducing the structurally altered gas molecules into an environment of a chemical process. The structurally altered gas molecules facilitate electron transfers during the chemical process, thereby increasing output of the chemical process.
    Type: Grant
    Filed: October 4, 2023
    Date of Patent: June 4, 2024
    Assignees: H2Plus LLC, H2Plus Operations, LLC
    Inventors: Gene Dedick, Gustav Eriksson, Jared Roberts, David Hauschild
  • Patent number: 11993683
    Abstract: Methods and systems for degradation of polymeric and non-polymeric substances is provided. An example method includes generating structurally altered gas molecules from water, where the structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a matter containing the polymeric substances and the non-polymeric substances, where upon being infused, the structurally altered gas molecules cause a decrease in concentration of the polymeric substances and the non-polymeric substances in the matter.
    Type: Grant
    Filed: December 8, 2023
    Date of Patent: May 28, 2024
    Assignees: H2PLUS LLC, H2Plus Operations, LLC
    Inventors: Gene Dedick, Jared Roberts
  • Patent number: 11993811
    Abstract: A method of identifying and quantifying copy number variations in a gene of interest for a genomic DNA sample includes (i) fragmenting a genomic DNA sample to produce a plurality of polynucleotide fragments, (ii) isolating a plurality of target polynucleotide fragments, (iii) sequencing the plurality of target polynucleotide fragments, (iv) aligning fragment sequences to a reference sequence, (v) calculating read depths for base positions of the plurality of target polynucleotide fragments, (vi) calculating copy number likelihoods for each base position of the reference sequence, (vii) performing a breakpoint analysis on a set of fragment sequences to identify at least one sequence variation located between selected breakpoint regions of the target gene and calculate modified copy number likelihoods for base positions of the reference sequence based on the at least one sequence variation, and (viii) determining whether the target gene includes at least one copy number variation.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: May 28, 2024
    Assignee: Myriad Women's Health, Inc.
    Inventors: Jared Robert Maguire, Alexander D. Robertson, Eric Andrew Evans
  • Publication number: 20240150846
    Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.
    Type: Application
    Filed: January 11, 2024
    Publication date: May 9, 2024
    Applicant: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker